Receives Australian HREC Approval and CTN Clearance for First-in-Human StudySAN MATEO, Calif.--(BUSINESS WIRE)--#ADC--Kivu Bioscience, Inc., a clinical-stage biotechnology company developing ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

Under the morning sun, I climb the steep cobblestone streets of the Albaicín. It’s my second day volunteering in music classes at the local primary school. Upon entering Colegio Público Gomez-Moreno, ...

Equity Insider News Commentary, The immuno-oncology market is forecast to grow from $65.22 billion in 2025 to $170.19 billion by 2032, fueled by checkpoint inhibitors, CAR-T cell therapy, and cancer ...

From billion-dollar licensing deals to advances in cancer therapies and artificial intelligence, Chinese biotech firms are ...

OJEMDA™ 2025 momentum reflected by Q4 and full year net product revenues of $52.8 million and $155.4 million, respectively2026 U.S. net product ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

However, psychologist Alan Rappoport coined a term to describe how people adapt to narcissistic family members: ...

All the way back from a long three month stint of posting on Instagram as much as a paid influencer, your favorite student who spent a semester abroad in France is back and better at correcting ...

Claire Kittle and Kristin Juszczyk discuss their lives as WAGs, their friendship and the inspiration behind their vlog series "Wife'd Up, Mic'd Up." ...

Few researchers have addressed the issue of the causality between public deficit and economic growth. Previous work has ...